Lymphangiogenesis-inducing device
Patent Information
- Application Number
- JP2024507750
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Filing Date
- 2024-03-12
- Publication Date
- 2024-11-26
AI Technical Summary
Current treatments for lymphedema, often resulting from lymphatic vessel blockages due to cancer treatments, are ineffective in promoting significant lymphatic vessel regeneration, leading to chronic and severe swelling and numbness in limbs.
A lymphangiogenesis inducing device with a puncturing member and a rod-shaped body that forms a wound in the target tissue site, utilizing a closing portion to prevent tissue fragments from entering the lumen and promote lymphatic vessel growth by creating a linear wound around blocked sites.
The device effectively induces lymphangiogenesis by forming reliable wounds that enhance lymphatic vessel generation during the healing process, improving lymphatic drainage and reducing lymphedema symptoms.
Abstract
Description
Lymphangiogenesis induction device
[0001] The present invention relates to a lymphangiogenesis induction device used in a procedure for inducing lymphangiogenesis.
[0002] Lymphatic vessels are one of the pathways that collect interstitial fluid in the body. When lymphatic vessels are blocked, interstitial fluid stagnates, which can lead to lymphedema, a condition that causes swelling and sensory paralysis in the limbs and other parts of the body, resulting in functional decline. Lymphedema is often caused by lymph node dissection and radiation therapy, which are performed as part of cancer treatments such as breast cancer treatment.
[0003] Lymphedema is a disease that is difficult to cure completely once it develops. Once it becomes chronic, it is difficult to improve easily, and if left untreated, it is said to become even more severe. A method of implanting a thread-like substance into subcutaneous tissue has been proposed as a treatment for lymphedema. For example, see JP 2020-127607 A, WO 2020 / 189157 A, JP 2021-104161 A, and "Brorson H. Liposuction Gives Complete Reduction of Chronic Large Arm Lymphedema After Breast Cancer. Acta Oncologica, 2000; 39(3):407-20."
[0004] Furthermore, "Joseph MR et al., Characterization of lymphangiogenesis in a model of adult skin regeneration. Am J Physiol Heart Circ Physiol. 2006 Sep; 291(3): H1402-H1410" and "Tammela & Alitalo, Lymphangiogenesis: Molecular mechanisms and future promise. Cell. 2010 Feb 19; 140(4): 460-76" report on the mechanism of lymphangiogenesis that occurs during the general wound healing process. Joseph MR et al. report that an immune response to wounds causes macrophages to accumulate, and that the accumulated macrophages produce VEGF-C (vascular endothelial growth factor C), which induces lymphangiogenesis. Tammela & Alitalo also report that lymphangiogenesis originates from existing lymphatic vessels and occurs by budding from these vessels.
[0005] In lymphangiogenesis induction procedures, a more effective lymphangiogenesis induction device is desired.
[0006] An object of the present invention is to solve the above-mentioned problems.
[0007] One aspect of the following disclosure resides in a lymphangiogenesis inducing device comprising: a puncturing member having a tip portion insertable into biological tissue and an inner cavity extending axially from the tip portion to a base end; a rod-shaped body having an outer diameter smaller than the inner cavity of the puncturing member, which is inserted into the inner cavity while forming a gap between it and the inner cavity and is displaceable in the front-to-rear direction along the inner cavity of the puncturing member; and an obstructing portion joined to the tip of the rod-shaped body, which has a cross section larger than the rod-shaped body and thereby obstructs the inner cavity, and which can protrude from the tip portion of the puncturing member as the rod-shaped body is displaced, wherein the obstructing portion has a wound forming portion that inflicts a wound on a target site of the biological tissue.
[0008] In the lymphatic vessel angiogenesis induction device according to the above aspect, the occlusion portion prevents tissue fragments from entering the lumen of the puncture member, thereby ensuring that the rod-shaped body and the occlusion portion can be reliably protruded from the puncture member. Therefore, the lymphatic vessel angiogenesis induction device can reliably form a wound that induces lymphatic vessel angiogenesis at a target site.
[0009] FIG. 1 is a longitudinal cross-sectional view of a lymphangiogenesis induction device according to a first embodiment. FIG. 2A is a transverse cross-sectional view showing the relationship between the diameters of the occlusion portion and a puncture member of the lymphangiogenesis induction device of FIG. 1, and FIG. 2B is an enlarged cross-sectional view of the rod-shaped body and the occlusion portion. FIG. 3A is an explanatory diagram of a step of puncturing biological tissue with the lymphangiogenesis induction device of FIG. 1, and FIG. 3B is an explanatory diagram of a step of moving the lymphangiogenesis induction device of FIG. 1 to a target site. FIG. 4A is an explanatory diagram of a step of protruding the rod-shaped body and the occlusion portion of FIG. 1 from the puncture member, and FIG. 4B is an explanatory diagram of a step of moving the rod-shaped body and the occlusion portion inside the biological tissue to create a linear injury in the biological tissue. FIG. 5A is a cross-sectional view of the vicinity of the distal end of a lymphangiogenesis induction device according to a second embodiment, and FIG. 5B is a perspective view of the rod-shaped body and the occlusion portion of FIG. 5A. FIG. 6A is a cross-sectional view of the vicinity of the distal end of a lymphangiogenesis induction device according to a third embodiment, and FIG. 6B is a perspective view of the vicinity of the distal end of the lymphangiogenesis induction device of FIG. 6A. Fig. 7A is a perspective view of an occlusion part according to a fourth embodiment, and Fig. 7B is a perspective view of an occlusion part according to a fifth embodiment. Fig. 8 is a cross-sectional view of a lymphangiogenesis inducing device according to a sixth embodiment.
[0010] (First embodiment) Lymphedema is believed to be caused by dysfunction of lymphatic vessels. When an obstruction occurs in a lymphatic vessel, the obstruction site forms a thickened and enlarged vessel wall. Such vessel wall narrows or obstructs the flow path of the collecting lymphatic vessel, inhibiting the drainage of interstitial fluid from the lymphatic vessel, and causing swelling of the limbs.
[0011] The lymphatic vessel neoplasia induction device 10 according to this embodiment is used for treating the above-described dysfunctional lymphatic tissue. The lymphatic vessel neoplasia induction device 10 promotes the formation of new lymphatic vessels by creating linear lesions at sites that serve as bypass routes for occluded sites.
[0012] As shown in Fig. 1, the lymphangiogenesis inducing device 10 has a puncturing member 12, a rod-shaped body 14, an occlusion portion 16, a puncturing member hub 18, and a rod-shaped body hub 20. The puncturing member 12 has a long, cylindrical shape. The puncturing member hub 18 is connected to a base end 12b of the puncturing member 12. The puncturing member hub 18 has an easy-to-grasp shape and is used to operate the puncturing member 12. An operator such as a doctor can operate the puncturing member 12 by holding the puncturing member hub 18.
[0013] The puncturing member 12 further has a needle tip 121 and an inner cavity 122. The needle tip 121 is formed at the distal end 12a of the puncturing member 12. The needle tip 121 has a blade surface 123 that is cut out obliquely with respect to the extension direction of the puncturing member 12. A sharp tip 124 that can puncture the biological tissue 90 is formed at the tip of the blade surface 123.
[0014] The lumen 122 is formed inside the puncture member 12. The lumen 122 extends along the central axis of the puncture member 12 and penetrates the puncture member 12 in the axial direction from the distal end 12a to the proximal end 12b. The distal end of the lumen 122 opens at the blade surface 123. The proximal end of the lumen 122 opens into the interior of the puncture member hub 18. The puncture member hub 18 has an interior hollow portion 181 that communicates with the lumen 122. As shown in FIG. 2A , the puncture member 12 and the lumen 122 are formed to have a circular cross section. The cross-sectional shapes of the puncture member 12 and the lumen 122 are not limited to a circular shape, and may be rectangular or polygonal.
[0015] The puncture member 12 can be made of a metal material such as stainless steel, aluminum or an aluminum alloy, titanium, or a titanium alloy (e.g., a nickel-titanium alloy). The material of the puncture member 12 may also be a hard resin or ceramic. The outer diameter D1 of the puncture member 12 is, for example, about 0.5 to 4.0 mm, and the inner diameter φ of the lumen 122 is, for example, about 0.25 to 3.5 mm.
[0016] As shown in FIG. 1 , the rod-shaped body 14 is inserted into the lumen 122 of the puncture member 12. The rod-shaped body 14 is a long, cylindrical member having a length approximately equal to or longer than the entire length of the puncture member 12. The rod-shaped body 14 may be a solid columnar member, or may be a rectangular tube or prism-shaped member. The base end 14b of the rod-shaped body 14 protrudes proximally beyond the puncture member 12. A rod-shaped body hub 20 is connected to the base end 14b of the rod-shaped body 14. The rod-shaped body hub 20 has a larger outer diameter than the rod-shaped body 14. An operator can grasp the rod-shaped body hub 20 to move the rod-shaped body 14 axially forward (displacement toward the distal end) or backward (displacement toward the proximal end). As shown in FIG. 2A , the outer diameter D2 of the rod-shaped body 14 is smaller than the inner diameter φ of the lumen 122. A gap 15 is formed between the rod-shaped body 14 and the lumen 122. The gap 15 is larger in the radial direction than the gap 13 described below. The gap 15 reduces the contact area between the rod-shaped body 14 and the bore 122, allowing the rod-shaped body 14 to advance or retreat inside the bore 122 with small sliding resistance.
[0017] As shown in FIG. 1 , the rod-shaped body 14 has an occlusion portion 16 at its tip end 14a. The occlusion portion 16 constitutes the wound forming portion 22 of the lymphatic vessel angiogenesis inducing device 10 of this embodiment. The occlusion portion 16 of this embodiment has a disk shape. The occlusion portion 16 is oriented approximately perpendicular to the extension direction of the rod-shaped body 14. The occlusion portion 16 is joined to the tip end 14a of the rod-shaped body 14 by various methods such as welding, brazing, adhesive bonding, or crimping. Therefore, the occlusion portion 16 displaces integrally with the rod-shaped body 14.
[0018] As shown in FIG. 2A , the outer diameter D3 of the occlusion portion 16 is slightly smaller than the inner diameter φ of the lumen 122 of the puncture member 12. The difference between the outer diameter D3 of the occlusion portion 16 and the inner diameter φ of the lumen 122 is, for example, 0.005 to 0.2 mm. In this manner, most of the lumen 122 is occluded by the occlusion portion 16. A narrow gap 13 is formed between the lumen 122 and the occlusion portion 16. This gap 13 is the gap between the occlusion portion 16 and the lumen 122, and is distinct from the gap 15 between the rod-shaped body 14 and the lumen 122. The gap 13 prevents tissue fragments from passing through, thereby preventing the lumen 122 on the proximal side of the occlusion portion 16 from being occluded by tissue fragments.
[0019] As shown in FIG. 2B , the occluding portion 16 extends axially for a length L1. The dimension of the occluding portion 16 in the length L1 direction can be set appropriately as long as the advancement of the occluding portion 16 is not hindered even if a tissue fragment enters the gap 13. For example, the length L1 of the occluding portion 16 can be set to three times or less the axial length of the blade surface 123 of the puncture member 12. More preferably, the length L1 can be set to be smaller than the inner diameter φ of the lumen 122. When the length L1 of the occluding portion 16 is smaller than the inner diameter φ of the lumen 122, malfunction of the occluding portion 16 is prevented even if a tissue fragment enters the gap 13. Another example of the length L1 is 0.2 to 3.49 mm. Note that if the length L1 of the occluding portion 16 is set too short, the rigidity of the occluding portion 16 decreases, making it more susceptible to deformation.
[0020] The occluding portion 16 of this embodiment has an edge 24 as the wound forming portion 22. The edge 24 is located on the outer periphery of the occluding portion 16. Specifically, the occluding portion 16 has an edge 24 at each of the corners on the distal and proximal ends of the outer periphery. The edge 24 is formed over the entire circumferential area of the occluding portion 16. The edge 24 has a small radius of curvature of 0.5 mm or less, preferably 0.001 mm or more and 0.5 mm or less. Such an edge 24 can form a wound in the biological tissue 90 when it advances or retreats inside the biological tissue 90.
[0021] The lymphatic vessel angiogenesis induction device 10 of this embodiment is configured as described above. The procedure using the lymphatic vessel angiogenesis induction device 10 includes the following steps.
[0022] Prior to puncturing the lymphatic vessel with the lymphangiogenesis inducing device 10, the operator first confirms the location of the obstructed lymphatic vessel. The location of the obstructed lymphatic vessel can be confirmed using methods such as ICG lymphangiography, lymphoscintigraphy, MRI, CT, and ultrasound imaging diagnosis. Next, the operator confirms the lymphatic vessel regeneration route. For example, the operator identifies the obstructed lymphatic vessel and determines a route that connects to an unobstructed lymphatic vessel adjacent to the obstructed site. Alternatively, for example, the operator determines a route that bypasses the obstructed lymphatic vessel site.
[0023] 3A , a step of puncturing the lymphangiogenesis induction device 10 is performed. The lymphangiogenesis induction device 10 punctures the target site from the needle tip 121 of the puncturing member 12. To prevent tissue fragments from entering the lumen 122 of the puncturing member 12, the blocking portion 16 is placed near the tip of the lumen 122 of the puncturing member 12.
[0024] 3B , a step is performed in which the lymphangiogenesis inducing device 10 is advanced to a predetermined site in the biological tissue 90. This step positions the needle tip 121 of the puncture member 12 at the predetermined site where wounding will begin. As the puncture member 12 is advanced, a portion of the biological tissue 90 enters the lumen 122. The occlusion portion 16 prevents tissue fragments from entering the lumen 122. In other words, the occlusion portion 16 prevents tissue fragments from entering the proximal side of the occlusion portion 16. This prevents a problem in which tissue fragments become stuck in the gap 15 between the rod-shaped body 14 and the lumen 122, preventing the rod-shaped body 14 from advancing.
[0025] Next, as shown in FIG. 4A , a step of creating a wound with the occlusion portion 16 is performed. In this step, the rod-shaped body 14 and the occlusion portion 16 are advanced distally relative to the puncture member 12. The above operation is performed by pushing the rod-shaped body hub 20 toward the distal end. This step may be performed by retracting the puncture member 12 toward the proximal end. Alternatively, this step may be performed by alternately retracting the puncture member 12 toward the proximal end and pushing the puncture member 12 toward the distal end. This exposes the occlusion portion 16 inside the biological tissue 90 as shown.
[0026] Next, as shown in FIG. 4B , a step is performed in which the occluding portion 16 is retracted proximally or advanced distally within the biological tissue 90. The advancement and retraction of the occluding portion 16 may be repeated multiple times as needed. This step causes the edge 24 of the occluding portion 16 to scrape against the biological tissue 90. As a result, numerous microscopic wounds are formed in the biological tissue 90 by the edge 24 of the occluding portion 16. The microscopic wounds are formed along the path of the occluding portion 16. To more reliably form the wounds, the rod-shaped body 14 may be advanced or the rod-shaped body 14 and the occluding portion 16 may be rotated as needed. This step includes an operation of retracting the puncture member 12 proximally. This step is completed when the puncture member 12 and the occluding portion 16 are completely withdrawn from the biological tissue 90.
[0027] This completes the creation of a lesion at one location. By repeating the above steps for the other pathways, lesions are created in all of the desired pathways, completing the procedure using the lymphangiogenesis inducing device 10 of this embodiment.
[0028] According to the above procedure, during the healing process of a linear wound, immune cells accumulate in the wound due to an immune response to the wound. The accumulated immune cells enhance the expression of lymphatic vessel growth factors. Therefore, the lymphangiogenesis inducing device 10 of this embodiment can induce lymphatic vessel neogenesis.
[0029] Second Embodiment As shown in Fig. 5A , in a lymphatic vessel angiogenesis induction device 10A of this embodiment, a rod-shaped body 14A and an occlusion section 16 are connected so as to form an L-shape in side view. Note that in the lymphatic vessel angiogenesis induction device 10A of this embodiment, components similar to those in the lymphatic vessel angiogenesis induction device 10 of Fig. 1 are designated by the same reference numerals, and detailed description thereof will be omitted. Furthermore, in the lymphatic vessel angiogenesis induction device 10A of Fig. 5A , the puncture member hub 18 and the rod-shaped body hub 20 are similar to those in Fig. 1, and therefore will not be shown or described.
[0030] 5B, the rod-shaped body 14A has an arc-shaped cross-sectional shape. The rod-shaped body 14A has a thin plate shape that is curved so as to fit along the inner cavity 122 of the puncture member 12. The blocking portion 16 is integrally connected to the rod-shaped body 14A. The blocking portion 16 is connected to the rod-shaped body 14A via a bent portion 161.
[0031] The lymphatic vessel angiogenesis induction device 10A of this embodiment is configured as described above. The lymphatic vessel angiogenesis induction device 10A achieves the same effects as the lymphatic vessel angiogenesis induction device 10 of the first embodiment. Furthermore, in this embodiment, the rod-shaped body 14A and the occlusion portion 16 can be formed by pressing a single metal plate, simplifying the structure and manufacturing process.
[0032] (Third embodiment) As shown in Fig. 6A , a lymphatic vessel angiogenesis induction device 10B of this embodiment has an occlusion section 16A that is inclined with respect to the central axis of the puncture member 12. Note that in the lymphatic vessel angiogenesis induction device 10B of this embodiment, components similar to those in the lymphatic vessel angiogenesis induction device 10 of Fig. 1 are designated by the same reference numerals, and detailed description thereof will be omitted. Furthermore, in the lymphatic vessel angiogenesis induction device 10B of Fig. 6A , the puncture member hub 18 and the rod-shaped body hub 20 are similar to those in Fig. 1, and therefore will not be shown or described here.
[0033] 6B , the angle of inclination of the occluding portion 16A relative to the axial direction is equal to the angle of inclination of the blade surface 123 of the puncture member 12 relative to the axial direction. In the initial state, the occluding portion 16A is positioned at the same position as the needle tip 121, and forms the same plane as the blade surface 123. The occluding portion 16A has edges 24A at the corners of its outer periphery. The occluding portion 16A inflicts a wound on the biological tissue 90 by means of the edges 24A.
[0034] The lymphatic vessel angiogenesis induction device 10B of this embodiment achieves the same effects as the lymphatic vessel angiogenesis induction device 10 of Fig. 1. Furthermore, the lymphatic vessel angiogenesis induction device 10B of this embodiment can further reduce the amount of tissue debris that invades the lumen 122. This allows the lymphatic vessel angiogenesis induction device 10B to more effectively prevent malfunctions due to clogging of the lumen 122 by tissue debris. Furthermore, because the occluding portion 16A is inclined relative to the rod-shaped body 14, resistance is less likely to be encountered inside the biological tissue 90 when the occluding portion 16A is advanced through the rod-shaped body 14, and the advancement operation can be easily performed.
[0035] (Fourth Embodiment) As shown in FIG. 7A , the occluding portion 16B of this embodiment has a side cutter. The occluding portion 16B has a plurality of sawtooth teeth 26 on the tip and outer periphery. This occluding portion 16B can be used in place of the occluding portion 16 of FIG. 1. As shown in FIG. 7A , the occluding portion 16B has a plurality of sawtooth teeth 26a extending radially toward the tip and sawtooth teeth 26b extending on the outer periphery. The sawtooth teeth 26b protrude from the outer periphery. The sharp ridges of these sawtooth teeth 26a, 26b constitute the edge 24B of this embodiment. In addition, the sawtooth teeth 26b have an inclined surface that generates a forward or backward directional force when the occluding portion 16B is rotated.
[0036] The occluding portion 16B of the present embodiment can inflict minute injuries on the biological tissue 90 not only by advancing and retreating but also by rotating. The occluding portion 16B can also advance by rotating, and inflict injuries on the biological tissue 90 as the occluding portion 16B advances.
[0037] Fifth Embodiment As shown in Figure 7B, an occluding portion 16C of this embodiment has a conical surface 162 on its outer periphery. This occluding portion 16C can replace the occluding portion 16 of Figure 1. The occluding portion 16C has a conical surface 162 whose outer diameter gradually decreases toward its distal end. The occluding portion 16C has its largest outer diameter at its proximal end. The occluding portion 16C occludes the lumen 122 (see Figure 1) at its proximal end, thereby preventing tissue fragments from entering the lumen 122.
[0038] The occluding portion 16C of this embodiment may be completely conical without a flat surface at the tip, or may have a conical surface whose outer diameter is greatest at the tip and gradually decreases toward the base end.
[0039] 8, a lymphatic vessel angiogenesis inducing device 10C of the present embodiment includes a puncturing member 12, a rod-shaped body 14A, an occlusion portion 16, a puncturing member hub 18, a rod-shaped body hub 20, a wire 28, and a wire hub 30. In the lymphatic vessel angiogenesis inducing device 10C of the present embodiment, the puncturing member 12, the puncturing member hub 18, and the rod-shaped body hub 20 are the same as the puncturing member 12, the puncturing member hub 18, and the rod-shaped body hub 20 in Fig. 1. In addition, in the lymphatic vessel angiogenesis inducing device 10C, the rod-shaped body 14A and the occlusion portion 16 are the same as the rod-shaped body 14A and the occlusion portion 16 shown in Figs. 5A and 5B.
[0040] The wire 28 is made of, for example, a metal wire. For example, one end 28a of the wire 28 is connected to the blocking portion 16. The wire 28 may be connected to the distal end side of the rod-shaped body 14A. That is, one end 28a of the wire 28 is connected to a portion of the rod-shaped body 14A or the blocking portion 16 that can protrude from the puncture member 12. A portion of the other end 28b of the wire 28 is housed in the gap 15 between the lumen 122 of the puncture member 12 and the rod-shaped body 14A. The other end 28b of the wire 28 is joined to a wire hub 30. The wire hub 30 is attached to the rod-shaped body hub 20. The wire hub 30 is displaceable in the axial direction relative to the puncture member hub 18 and the rod-shaped body hub 20.
[0041] As shown in the figure, when the wire hub 30 is advanced with the blocking portion 16 protruding distally from the distal end 12a of the puncture member 12, the portion of the wire 28 exposed from the puncture member 12 becomes loose and spreads outward in the axial direction. When the wire hub 30 is pulled proximally, the wire 28 is pulled proximally and becomes taut, positioning the rod-shaped body 14A in the vicinity of the rod-shaped body 14A in parallel.
[0042] The lymphatic vessel angiogenesis inducing device 10C of this embodiment can repeatedly relax and tighten the wire 28 inside the biological tissue 90 by manipulating the wire hub 30. Subcutaneous tissue (mainly adipose tissue) where interstitial fluid accumulates is flexible. When the wire 28 relaxes, the biological tissue 90 enters the gap 13 between the wire 28 and the rod-shaped body 14A. When the wire hub 30 is then retracted, the wire 28 becomes tense, and the flexible biological tissue 90 (mainly adipose tissue) that has entered between the wire 28 and the rod-shaped body 14A is cut, creating a wound. Such a wound induces lymphatic vessel angiogenesis during the healing process.
[0043] As described above, the lymphatic vessel angiogenesis inducing device 10C of this embodiment can inflict lesions by relaxing and tensioning the wire 28, in addition to inflicting lesions by advancing and retracting the rod-shaped body 14A and the obstructing portion 16. Inflicting lesions by the wire 28 can inflict lesions over a wider range than the range of movement of the obstructing portion 16. Therefore, the lymphatic vessel angiogenesis inducing device 10C can more effectively promote lymphatic vessel angiogenesis.
[0044] The lymphangiogenesis induction devices 10, 10A, 10B, and 10C described above can be summarized as follows.
[0045] Each of the lymphatic vessel angiogenesis inducing devices 10, 10A, 10B, and 10C comprises a puncturing member 12 having a tip 12a that can be inserted into biological tissue 90 and an inner cavity 122 that extends axially from the tip to the base end; a rod-shaped body 14 that has an outer diameter smaller than the inner cavity of the puncturing member, that is inserted into the inner cavity while forming a gap 15 between it and the inner cavity, and that is displaceable in the front-to-rear direction along the inner cavity of the puncturing member; and an obstructing portion 16, 16A, 16B, and 16C that is joined to the tip of the rod-shaped body, that has a cross-section larger than the rod-shaped body, and that obstructs the inner cavity and that can protrude from the tip of the puncturing member as the rod-shaped body is displaced. The obstructing portion has a wound-forming portion 22 that inflicts a wound on a target site of the biological tissue.
[0046] In the lymphatic vessel angiogenesis induction device, the occlusion portion prevents tissue fragments from entering the lumen of the puncture member, thereby ensuring that the rod-shaped body and the occlusion portion can be reliably protruded from the puncture member. Therefore, the lymphatic vessel angiogenesis induction device can reliably form a wound that induces lymphatic vessel angiogenesis at a target site.
[0047] In the lymphatic vessel angiogenesis induction device, the wound forming portion may have sharp edges 24, 24A, 24B formed on the outer periphery of the obstructing portion. This lymphatic vessel angiogenesis induction device can create a wound at a predetermined site to induce lymphatic vessel angiogenesis by moving the obstructing portion within biological tissue.
[0048] In the lymphangiogenesis inducing device, the wound forming portion may have an uneven shape formed on the surface of the occlusion portion. This lymphangiogenesis inducing device can form a minute wound by rubbing the uneven shape against the biological tissue.
[0049] In the lymphangiogenesis induction device, the wound forming section may have a side cutter formed in the obstructing section. This lymphangiogenesis induction device can efficiently form wounds in biological tissue with a large number of saw teeth.
[0050] In the lymphangiogenesis induction device, the occlusion portion may have a disk shape. This lymphangiogenesis induction device can simplify its structure and manufacturing process, making it easier to manufacture.
[0051] In the lymphangiogenesis inducing device described above, the wound forming portion may have a wire 28, one end 28a of which is attached to the obstructing portion and which passes through the inside of the lumen. This lymphangiogenesis inducing device can form wounds over a wider area by relaxing and tensioning the wire 28.
[0052] In the lymphatic vessel angiogenesis induction device, the rod-shaped body may be movable in the axial direction while being rotated about the axis. This lymphatic vessel angiogenesis induction device can efficiently create multiple wounds by axial movement accompanied by rotation.
[0053] The lymphangiogenesis inducing device may include a puncturing member hub (18) that supports the base end of the puncturing member and a rod-shaped body hub (20) that supports the base end of the rod-shaped body, and the rod-shaped body hub may be moved relative to the puncturing member hub to allow the rod-shaped body to protrude from and retract into the tip end of the puncturing member. This lymphangiogenesis inducing device has excellent operability because the rod-shaped body and the obstructing portion can be protruded through the rod-shaped body hub.
[0054] The lymphangiogenesis inducing device may include a puncture member hub that supports the base end of the puncture member, a rod-shaped body hub that supports the base end of the rod-shaped body, and a wire hub 30 joined to the other end 28b of the wire, wherein the rod-shaped body hub can be moved relative to the puncture member hub to allow the rod-shaped body to protrude from and retract into the tip end of the puncture member, and the wire hub can be moved relative to the rod-shaped body hub to loosen or tighten the wire. This lymphangiogenesis inducing device has excellent operability because the loosening and tension of the wire can be controlled via the wire hub.
[0055] The present invention is not limited to the above-described embodiment, and various configurations can be adopted without departing from the gist of the present invention.
Claims
1. A puncture member having a distal end portion that can be inserted into biological tissue and an inner cavity extending in an axial direction from the distal end portion to a base end; a rod-shaped body having an outer diameter smaller than the inner cavity of the puncture member, which is inserted through the inner cavity while forming a gap between the rod-shaped body and the inner cavity, and which is displaceable in a front-rear direction along the inner cavity of the puncture member; a blocking portion that is joined to the tip of the rod-shaped body, has a cross section larger than that of the rod-shaped body, and blocks the inner cavity, and is capable of protruding from the tip of the puncture member in response to displacement of the rod-shaped body, The occlusion unit has a wound forming unit that inflicts a wound on a target site of the biological tissue. Lymphangiogenesis induction device.
2. 2. The lymphangiogenesis induction device according to claim 1, wherein the wound forming portion has a sharp edge formed on an outer periphery of the obstructing portion. Lymphangiogenesis induction device.
3. 2. The lymphangiogenesis inducing device according to claim 1, wherein the wound forming portion has an uneven shape formed on a surface of the obstructing portion. Lymphangiogenesis induction device.
4. The lymphangiogenesis induction device according to claim 1 , wherein the wound forming portion has a side cutter formed in the obstructing portion. Lymphangiogenesis induction device.
5. 2. The lymphangiogenesis induction device according to claim 1, wherein the occlusion portion has a disk shape. Lymphangiogenesis induction device.
6. The lymphangiogenesis induction device according to any one of claims 1 to 5, wherein the wound forming portion has one end attached to the obstructing portion and a wire passing through the inside of the lumen. Lymphangiogenesis induction device.
7. 2. The lymphangiogenesis induction device according to claim 1, wherein the rod-shaped body is movable in the axial direction while being rotated about the axis. Lymphangiogenesis induction device.
8. 2. The lymphangiogenesis induction device according to claim 1, further comprising: a puncture member hub that supports a base end of the puncture member; and a rod-shaped body hub that supports a base end of the rod-shaped body, The rod-shaped body hub is movable relative to the puncture member hub, thereby allowing the rod-shaped body to protrude and retract from the tip end of the puncture member. Lymphangiogenesis induction device.
9. 7. The lymphangiogenesis inducing device according to claim 6, comprising: a puncture member hub supporting a base end of the puncture member; a rod-shaped body hub supporting a base end of the rod-shaped body; and a wire hub joined to the other end of the wire; the rod-shaped body hub is movable relative to the puncture member hub, thereby allowing the rod-shaped body to protrude from and retract into the tip end of the puncture member; The wire hub is moved relative to the rod-shaped body hub to loosen or tighten the wire. Lymphangiogenesis induction device.
